Effects of commercially produced almond by-products on chemotherapy-induced mucositis in rats

doi:10.4291/wjgp.v8.i4.176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7733)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

498

WORD

231

HTML

4022

Figures (1-5)

271

Tables (1-4)

264

Sum=5286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1068

Download

1379

Sum=2447

Nov 15, 2017 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Pathophysiol. Nov 15, 2017; 8(4): 176-187
Published online Nov 15, 2017. doi: 10.4291/wjgp.v8.i4.176

Table 4 Severity scoring parameters for jejunum and ileum

		Villus blunting	Crypt distortion	Reduction in goblet cell numbers	Dilation of lymphatics	Thickening of submucosa	Thickening of muscularis externa	Enterocyte disruption	Lymphocytic and PMN infiltration
Sal + PBS	J	0	0	0	0	0.06 ± 0.06	0	0	0
Sal + PBS	I	0.19 ± 0.12	0	0	0	0.31 ± 0.15	0.19 ± 0.12	0	0
Sal + AHE1	J	0	0	0	0	0.13 ± 0.08	0	0	0
Sal + AHE1	I	0	0	0	0	0.31 ± 0.15	0.13 ± 0.12	0	0
Sal + AHE2	J	0	0	0	0	0.21 ± 0.14	0	0	0
Sal + AHE2	I	0.07 ± 0.07	0	0.14 ± 0.13	0	0.07 ± 0.07	0.07 ± 0.07	0	0
Sal + ABW1	J	0.13 ± 0.12	0	0	0	0.13 ± 0.12	0	0	0
Sal + ABW1	I	0	0.06 ± 0.06	0	0	0.13 ± 0.12	0.06 ± 0.06	0	0
Sal + ABW2	J	0	0	0	0	0.25 ± 0.13	0.13 ± 0.08	0	0
Sal + ABW2	I	0.13 ± 0.12	0	0.12 ± 0.12	0	0.38 ± 0.15	0.19 ± 0.12	0	0
5-FU +PBS	J	1.63 ± 0.15^b	1.38 ± 0.17^b	1.81 ± 0.12^b	1 ± 0^b	0.88 ± 0.12^b	0.88 ± 0.12^b	1 ± 0^b	1 ± 0^b
5-FU +PBS	I	1.56 ± 0.24^b	1.62 ± 0.17^b	1.89 ± 0.12^b	1 ± 0^b	0.88 ± 0.21^b	0.63 ± 0.17^a	1 ± 0.18^b	1 ± 0^b
5-FU +AHE1	J	1.71 ± 0.17^b	1.43 ± 0.19^b	1.86 ± 0.13^b	1 ± 0^b	0.79 ± 0.14^b	0.71 ± 0.14^b	1 ± 0^b	1 ± 0^b
5-FU +AHE1	I	1.64 ± 0.17^b	1.57 ± 0.21^b	1.79 ± 0.2^b	1 ± 0^b	1 ± 0^b	1 ± 0^b	1 ± 0^b	1 ± 0^b
5-FU +AHE2	J	1.79 ± 0.14^b	1.71 ± 0.17^b	2 ± 0^b	0.93 ± 0.07^b	1 ± 0^b	0.93 ± 0.07^b	1 ± 0^b	1 ± 0^b
5-FU +AHE2	I	1.86 ± 0.13^b	1.57 ± 0.19^b	1.93 ± 0.07^b	1 ± 0^b	0.71 ± 0.2^b	0.64 ± 0.22^a	1 ± 0^b	1 ± 0^b
5-FU + ABW1	J	1.44 ± 0.16^b	1.25 ± 0.15^b	1.63 ± 0.17^b	1 ± 0^b	0.94 ± 0.19^b	0.88 ± 0.19^b	0.88 ± 0.12^b	0.88 ± 0.12^a
5-FU + ABW1	I	1.25 ± 0.15^b	1.25 ± 0.15^b	1.63 ± 0.17^b	1 ± 0^b	0.88 ± 0.12^b	0.88 ± 0.12^b	1 ± 0^b	1 ± 0^b
5-FU + ABW2	J	1.75 ± 0.13^b	1.19 ± 0.12^b	1.94 ± 0.06^b	1 ± 0^b	0.88 ± 0.15^b	0.63 ± 0.17^b	1.13 ± 0.12^b	1 ± 0^b
5-FU + ABW2	I	1.75 ± 0.15^b	1.56 ± 0.16^b	1.75 ± 0.15^b	1 ± 0^b	0.94 ± 0.06^b	0.69 ± 0.15^a	1 ± 0^b	1 ± 0^b

Data are expressed as means ± SEM.

^aP < 0.05 vs saline + PBS,

^bP < 0.01 vs saline + PBS. 5-FU: 5-fluorouracil; PBS: Phosphate-buffered saline; AHE: Almond hull extract; ABW: Almond blanched water.

Citation: Whittaker AL, Zhu Y, Howarth GS, Loung CS, Bastian SEP, Wirthensohn MG. Effects of commercially produced almond by-products on chemotherapy-induced mucositis in rats. World J Gastrointest Pathophysiol 2017; 8(4): 176-187
URL: https://www.wjgnet.com/2150-5330/full/v8/i4/176.htm
DOI: https://dx.doi.org/10.4291/wjgp.v8.i4.176